In 2020, Orgenesis's Italian branch became a partner in a gene therapy research center in Padua, Italy.

Reasoning:

• The Padua-based research center in question is the National Center for Gene Therapy and Drugs based on RNA Technology (Centro Nazionale di Ricerca "Sviluppo di terapia genica e farmaci con tecnologia a RNA"), a foundation created by the University of Padua¹².
• Orgenesis's Italian branch (Orgenesis Italy Srl) is indeed listed among the 49 partner entities of that center, and Orgenesis is described as one of the project's founders³¹.
• However, the date is wrong. The foundation was established by the University of Padua on 8 June 2022, and its governing bodies were elected on 30 September 2022 — not 2020¹².
• Orgenesis Italy SRL was itself incorporated in 2022 (and the parent's SEC filing states Orgenesis "has joined an Italian consortium" at that time), so the Italian branch did not exist in 2020⁴⁵.
• The "2020" appears to stem from a different event: Heiko von der Leyen became Medical Director of Orgenesis in December 2020⁶⁷. He was only appointed to the Padua center's supervisory board in September 2022²⁸¹.
• So the underlying relationship (Orgenesis's Italian branch is a partner in the Padua gene-therapy center) is accurate, but the stated year — the central element of the claim — is incorrect by two years.

Overall validity: 35%